Search Results | Blood | American Society of Hematology

1-20 of 102

2 3 4 5

Sort by

Sort Order Select

Journal Articles

The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders

Blood (2021) 138 (26): 2781–2798.

DOI: https://doi.org/10.1182/blood.2021012900

Published: 2021

Includes: Supplemental data

Journal Articles

Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia

Blood (2021) 138 (19): 1885–1895.

DOI: https://doi.org/10.1182/blood.2020010603

Published: 2021

Includes: Supplemental data

Journal Articles

β-Hemoglobinopathies lead the way

Yogen Saunthararajah

Blood (2021) 137 (12): 1567–1569.

DOI: https://doi.org/10.1182/blood.2020009961

Published: 2021

Journal Articles

the Impact of Clonal Dynamics on Prognosis and Outcome in Myelodysplastic Syndromes

Hideki Makishima, MD PhD FACP., Tetsuichi Yoshizato, MD PhD, Kenichi Yoshida, MD PhD, Mikkael A. Sekeres, MD MS, Tomas Radivoyevitch, PhD, Hiromichi Suzuki, MD PhD, Bartlomiej P Przychodzen, MSc, Yasunobu Nagata, MD, PhD, Manja Meggendorfer, PhD, Masashi Sanada, MD PhD, Yusuke Okuno, MD PhD, Cassandra M. Hirsch, BSc, Teodora Kuzmanovic, Yusuke Shiozawa, MD, Yusuke Sato, MD PhD, Aiko Sato-Otsubo, Thomas LaFramboise, PhD, Naoko Hosono, MD, PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Claudia Haferlach, MD, Wolfgang Kern, MD, Hiroko Tanaka, BA, Ines Gómez-Seguí, MD PhD, Holleh Husseinzadeh, MD, Swapna Thota, MD, Kathryn M. Guinta, Brittney Dienes, Tsuyoshi Nakamaki, MD, Shuichi Miyawaki, MD PhD, Yogen Saunthararajah, MD, Shigeru Chiba, MD, PhD, Satoru Miyano, PhD, Lee-Yung Shih, MD, Torsten Haferlach, MD, Seishi Ogawa, MD PhD, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 4287.

DOI: https://doi.org/10.1182/blood.V128.22.4287.4287

Published: 2016

Journal Articles

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

Sudhakiranmayi Kuravi, M.S., Preethi Kunchala, M.S., Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Yogen Saunthararajah, MD, Kojo S. J. Elenitoba-Johnson, MD, Jensen Roy, MD, Joseph McGuirk, DO, Ramesh Balusu, PhD

Blood (2016) 128 (22): 4127.

DOI: https://doi.org/10.1182/blood.V128.22.4127.4127

Published: 2016

Journal Articles

The Role of LUC7L2 in Splicing and MDS

Courtney Elizabeth Hershberger, BS, Naoko Hosono, MD, PhD, Jarnail Singh, PhD, Rosemary C Dietrich, M.S., Xiaorong Gu, PhD, Hideki Makishima, MD PhD FACP., Yogen Saunthararajah, MD, Jaroslaw P Maciejewski, MD PhD FACP, Richard A Padgett, PhD

Blood (2016) 128 (22): 5504.

DOI: https://doi.org/10.1182/blood.V128.22.5504.5504

Published: 2016

Journal Articles

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia Undergoing Remission Induction Therapy

Sudipto Mukherjee, MD, PhD, M.P.H., Paul Elson, PhD, Samjhana Bogati, BSN, Ashley Woltman, BSN, RN, John Desamito, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, Yogen Saunthararajah, MD, Jaroslaw P Maciejewski, MD PhD FACP, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS

Blood (2016) 128 (22): 447.

DOI: https://doi.org/10.1182/blood.V128.22.447.447

Published: 2016

Journal Articles

Germline Variants of RUNX-1 in Myeloid Malignancy

Alek d Nielsen, B.S., Sayer Alharbi, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Mikkael A. Sekeres, MD MS, Yogen Saunthararajah, MD, Hetty E. Carraway, MD MBA, Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 3926.

DOI: https://doi.org/10.1182/blood.V128.22.3926.3926

Published: 2016

Journal Articles

Prognostic Impact of Molecular Mutations in AML at First Relapse

Anjali S. Advani, MD, Paul Elson, PhD, Valeria Visconte, PhD, Jennifer S. Carew, PhD, Jaime Fensterl, Bartlomiej Przychodzen, MSc, Mikkael A. Sekeres, MD MS, Cassandra M Hirsch, Alek Nielsen, John Desamito, Hetty E. Carraway, MD MBA, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Sudipto Mukherjee, MD PhD, Ronald M. Sobecks, MD, Matt Kalaycio, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 3825.

DOI: https://doi.org/10.1182/blood.V126.23.3825.3825

Published: 2015

Journal Articles

Serial Sequencing in Myelodysplastic Syndromes Reveals Dynamic Changes in Clonal Architecture and Allows for a New Prognostic Assessment of Mutations Detected in Cross-Sectional Testing

Blood (2015) 126 (23): 709.

DOI: https://doi.org/10.1182/blood.V126.23.709.709

Published: 2015

Journal Articles

Real World Outcomes of Less Well-Characterized Acute Leukemias: A Population-Based Survival Analysis Using SEER Registry (1973-2012)

Surbhi Sidana, MD, Paul Elson, PhD, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD PhD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD

Blood (2015) 126 (23): 4491.

DOI: https://doi.org/10.1182/blood.V126.23.4491.4491

Published: 2015

Journal Articles

Survival Outcomes of Leukemias and Myelodysplastic Syndromes Occurring As Second Cancers in the United States: A SEER Registry-Based Population Analysis

Blood (2015) 126 (23): 2507.

DOI: https://doi.org/10.1182/blood.V126.23.2507.2507

Published: 2015

Journal Articles

The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice

Shuaiying Cui, Kim-Chew Lim, Lihong Shi, Mary Lee, Natee Jearawiriyapaisarn, Greggory Myers, Andrew Campbell, David Harro, Shigeki Iwase, Raymond C. Trievel, Angela Rivers, Joseph DeSimone, Donald Lavelle, Yogen Saunthararajah, James Douglas Engel

Blood (2015) 126 (3): 386–396.

DOI: https://doi.org/10.1182/blood-2015-02-626259

Published: 2015

Includes: Supplemental data

Journal Articles

Targets of opportunity for precision medicine

Yogen Saunthararajah

Blood (2015) 125 (20): 3041–3042.

DOI: https://doi.org/10.1182/blood-2015-04-638270

Published: 2015

Journal Articles

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Valeria Visconte, PhD, Rokana Taftaf, MD, Heesun J. Rogers, MD PhD, Jing Ai, MD PhD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Yogen Saunthararajah, MD, Brady L Stein, MDMHS, Ramon V. Tiu, MD

Blood (2014) 124 (21): 1834.

DOI: https://doi.org/10.1182/blood.V124.21.1834.1834

Published: 2014

Journal Articles

Time to Complete Remission As a Function of Kinetics of White Blood Cell Elimination and Recovery in Acute Myeloid Leukemia Patients Undergoing Remission Induction Chemotherapy

Umera Thebo, MD, Tomas Radivoyevitch, PhD, Surbhi Sidana, MD, Cassandra Fincher, Amanda L. Maggiotto, BS, CCRP, Yogen Saunthararajah, MD, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Betty K. Hamilton, MD, Matt E. Kalaycio, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD MPH

Blood (2014) 124 (21): 5266.

DOI: https://doi.org/10.1182/blood.V124.21.5266.5266

Published: 2014

Journal Articles

Effect of Early Non-Hematologic Treatment Toxicity on Complete Remission (CR) and Time to CR in Acute Myeloid Leukemia Patients Undergoing Remission Induction Chemotherapy

Surbhi Sidana, MD, Mayur Narkhede, MD, Tomas Radivoyevitch, PhD, Moshe C. Ornstein, MD MA, Cassandra Fincher, Amanda L. Maggiotto, BS, CCRP, Yogen Saunthararajah, MD, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Hetty E. Carraway, MD MBA, Betty K. Hamilton, MD, Matt E. Kalaycio, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD MPH

Blood (2014) 124 (21): 2279.

DOI: https://doi.org/10.1182/blood.V124.21.2279.2279

Published: 2014

Journal Articles

Haploinsufficiency and Deletions of G3BP1 on Chromosome 5q Result in Induction of TP53

Naoko Hosono, MDPhD, Mahfouz Reda, MDPhD, Bartlomiej P Przychodzen, Chantana Polprasert, MD, Latifa Zekri, PhD, Michael J. Clemente, Jamal Tazi, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD, Hideki Makishima, MD PhD

Blood (2014) 124 (21): 784.

DOI: https://doi.org/10.1182/blood.V124.21.784.784

Published: 2014

Journal Articles

Combination with Thu to Address Pharmacologic Limitations of Decitabine, Interim PK/PD from a Phase 1/2 Clinical Trial of Oral Thu-Decitabine in Sickle Cell Disease

Donald Lavelle, PhD, Michel Gowhari, DO, Michael Pacini, PharmD, Lani Krauz, RN, Johara Hassan, MD, Vinzon Ibanez, Maria A. Ruiz, MSc, Daisy Pacelli, BSc, Chaher Alhandalous, MD, Mitch A. Phelps, PhD, Kathleen Fenner, BS,MS, Reda Z. Mahfouz, MDPhD, John Barnard, Lewis L. Hsu, MD PhD, Victor R. Gordeuk, MD, Joseph DeSimone, PhD, Yogen Saunthararajah, MD, Robert E. Molokie, MD

Blood (2014) 124 (21): 90.

DOI: https://doi.org/10.1182/blood.V124.21.90.90

Published: 2014

Journal Articles

In Analogy to AML, MDS Can be Sub-Classified By Ancestral Mutations

Blood (2014) 124 (21): 823.

DOI: https://doi.org/10.1182/blood.V124.21.823.823

Published: 2014

2 3 4 5

NARROW

The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders

Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia

β-Hemoglobinopathies lead the way

the Impact of Clonal Dynamics on Prognosis and Outcome in Myelodysplastic Syndromes

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

The Role of LUC7L2 in Splicing and MDS

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia Undergoing Remission Induction Therapy

Germline Variants of RUNX-1 in Myeloid Malignancy

Prognostic Impact of Molecular Mutations in AML at First Relapse

Serial Sequencing in Myelodysplastic Syndromes Reveals Dynamic Changes in Clonal Architecture and Allows for a New Prognostic Assessment of Mutations Detected in Cross-Sectional Testing

Real World Outcomes of Less Well-Characterized Acute Leukemias: A Population-Based Survival Analysis Using SEER Registry (1973-2012)

Survival Outcomes of Leukemias and Myelodysplastic Syndromes Occurring As Second Cancers in the United States: A SEER Registry-Based Population Analysis

The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice

Targets of opportunity for precision medicine

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Time to Complete Remission As a Function of Kinetics of White Blood Cell Elimination and Recovery in Acute Myeloid Leukemia Patients Undergoing Remission Induction Chemotherapy

Effect of Early Non-Hematologic Treatment Toxicity on Complete Remission (CR) and Time to CR in Acute Myeloid Leukemia Patients Undergoing Remission Induction Chemotherapy

Haploinsufficiency and Deletions of G3BP1 on Chromosome 5q Result in Induction of TP53

Combination with Thu to Address Pharmacologic Limitations of Decitabine, Interim PK/PD from a Phase 1/2 Clinical Trial of Oral Thu-Decitabine in Sickle Cell Disease

In Analogy to AML, MDS Can be Sub-Classified By Ancestral Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only